Primary Thyroid METS 4CA Complicated w/Renal CA & CLL Leukemia: 74 yr. Male

Previous history of I-131 treatment with virtual no uptake & failed treatment outcomes

2/99 Surgery: Left Thyroid lobectomy indicating thyroid CA w/Hurthle Cell Diff w/papillary CA & positive thyroglobulin. Vertebral body & epidural space METS + 6th, 7th & partial 9th rib resection indicating MET thyroid CA.

3/26/99 Surgery: Additional rib resection + rt. Chest wall 8 cm x 6 cm mass pathology: thyroid CA. Right kidney nephrectomy w/multiple tumors: mixed clear cell & granular renal cell primary CA

12/2001 PET Scan: Multiple hypermetabolic foci: Right, left upper & middle lung zones, right hilar area, right anterior ribs, proximal right femur consistent with bone marrow METS, superior & medial to right kidney suggesting adrenal gland        involvement, pelvic uptake, right lateral basal segment of lung, uptake in the right & left residual area of both lobes of thyroid, left lobe of liver and additional foci in the mediastinal area.

3/2002 I-131 Study/Scan: Hypermetabolic Uptake: Right & Left thyroid previous lobe areas, left lobe of liver and right lingual area. Absent foci was both lungs, indicating lung METS was probably renal cell CA primary METS.

10/30/02 Initiated BioImmune oral + I.V. program

Given 3 weeks to live by patient’s Oncologist in 10/2004

11/25/2002 PET Whole Body Scan: Total resolution of numerous previous intense hypermetabolic areas: right renal & suprarenal areas, right midchest & posterior pleural lung regions, slight activity in the right paraspinal region, T6-7. New activity in the right hip and greater trochanter of 1 cm compared to previous PET   of 12/2001

12/16/2002 High Resolution CAT scan: Complete resolution of new foci from PET Scan of 11/25/2003 !! Patient is in full remission!!

Maintained Nutraceutical Maintenance Program

12/2003 Patient is still in complete remission!!

AML Leukemia Stage 4

5/14/02 Diagnosed by Johns Hopkins with very aggressive AML Leukemia: given 12 days to live.
WBC 7.61, Plt 44.9, Blast 8%.
Bone marrow biopsy: 95% immature myeloid precursors.
Grey countenance & dying hourly.

5/17/02 Initiated oral & I.V. protocol

5/30/02 WBC 30.3, Plt 28, Blast 10%

6/5/02 WBC 31.7, Plt 18, Blast 3%

8/28/02 WBC 7.6, Plt 239, Blast 0.0% & feeling good!!


Visit our New Cancer Center Website for more Information

Return to Case Studies .:. Cancer Center